HPV Testing and PAP Test Market Size is Poised to Reach US$ 4.0 Billion in 2022

Industry Overview of HPV Testing and PAP Test Market
HPV testing and PAP test refer to medical procedures that are used to detect human papillomavirus (HPV), an infection transmitted through sexual activity that is known to cause cancer in the cervix, and oropharynx. These diagnostic examinations involve the microscopic examination of specimens and screening for cervical, head, and neck cancers. HPV testing and PAP test specifically assess the presence of the human papillomavirus, which can indicate the potential development of genital warts and identify changes in cervical cells while detecting the presence of abnormal cells, respectively. Consequently, they find extensive utilization across the globe.

How Big Is the HPV Testing and PAP Test Market?
The global HPV testing and PAP test market size reached US$ 4.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.6 Billion by 2028, exhibiting a growth rate (CAGR) of 5.92% during 2023-2028.

Request For Sample Report: https://www.imarcgroup.com/hpv-testing-pap-test-market/requestsample

Global HPV Testing and PAP Test Market Trends and Drivers:
The HPV testing and PAP test market is primarily driven by the increasing prevalence of cervical cancer, particularly among adult populations, caused by the presence of papillomavirus. Furthermore, the introduction of machine-assisted screenings using plasma and cell-free DNA that has contributed to the early detection and monitoring of HPV-infected cancers is acting as another significant growth-inducing factor. Apart from this, the emerging trend among key players in the industry to engage in clinical trials, research and development (R&D) activities, and new product launches, such as user-friendly home HPV screening tests, which have gained significance during the COVID-19 pandemic, is also positively influencing the global market. Additionally, the growing healthcare industry across countries and the implementation of favorable initiatives by government bodies and non-governmental organizations (NGOs) to raise awareness about the causes of cervical cancer and the benefits of HPV testing and PAP test are expected to bolster the market over the forecasted period.

What Is Included In Market Segmentation?
The report has been segmented the market into following categories:
Breakup by Test Type:
HPV Test
Pap Test
Co-testing

Breakup by Product:
Instruments
Consumables
Services

Breakup by Application:
Cervical Cancer Screening
Vaginal Cancer Screening

Breakup by End User:
Hospitals and Clinics
Laboratories
Diagnostic Centers
Others

Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

The report provides a comprehensive analysis of the industry key players listed below:
The Major Players in the market are Abbott Laboratories, Arbor Vita Corporation, AstraZeneca plc, Becton Dickinson and Company, Biocon Limited, bioMérieux SA, Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., NURX Inc. (Thirty Madison Inc.), Qiagen N.V., Quest Diagnostics Incorporated, Seegene Inc. and Thermo Fisher Scientific Inc.

Ask Analyst for 10% free customized report: https://www.imarcgroup.com/request?type=report&id=5889&flag=C

Related Posts:
Motor Insurance Market Report:
https://www.openpr.com/news/3095141/motor-insurance-market-size-is-projected-to-reach-us-1-282-1

Dialysis Market Report:
https://www.openpr.com/news/3095218/dialysis-market-size-is-projected-to-reach-us-148-8-billion

GCC Data Center Market Report:
https://www.openpr.com/news/3095394/gcc-data-center-market-size-is-projected-to-reach-us-3-13-billion

Food Packaging Equipment Market Report:
https://www.openpr.com/news/3096847/food-packaging-equipment-market-size-is-projected-to-reach-us

Contract Packaging Market Report:
https://www.openpr.com/news/3096947/contract-packaging-market-size-is-projected-to-reach-us-103-0

Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.